Abstract
Renal dysfunction is a growing problem in patients awaiting liver transplant. New strategies have been developed to deal with this problem. Combined liver/kidney transplant is a viable option for the patient with combined end-organ damage. There is growing concern over the long-term consequence of chronic calcineurin inhibitor therapy for chronic kidney disease and end-stage renal disease. Multiple new strategies to deal with this have been proposed. They have had variable success, and further research is needed.
Original language | English (US) |
---|---|
Pages (from-to) | 116-122 |
Number of pages | 7 |
Journal | Current opinion in organ transplantation |
Volume | 9 |
Issue number | 2 |
DOIs | |
State | Published - Jan 1 2004 |
Keywords
- Combined kidney-liver transplant
- Hepatorenal syndrome
- MARS
- Nephrotoxicity after liver transplant
- Terlipressin
ASJC Scopus subject areas
- Immunology and Allergy
- Transplantation